Novo Nordisk 29 abr 2026 Novo Nordisk faces competition from Canadian generic version of Ozempic - medwatch.com
Novo Nordisk 28 abr 2026 Novo Holdings makes 1st commitment to Korean PEF as global pharma capital targets K-bio - KED Global
Novo Nordisk 27 abr 2026 The 10 Most Influential Health and Life Science Companies of 2026 - Time Magazine
Novo Nordisk 23 abr 2026 With trial win, Novo Nordisk eyes adolescent diabetes approval for oral semaglutide - Fierce Pharma
Novo Nordisk 20 abr 2026 Novo Nordisk to seek oral sickle cell therapy approval after Phase III victory - Clinical Trials Arena
FierceBiotech 8 abr 2026 With $2B Novo deal in the books, Vivtex isn't 'limited to being just a drug delivery company': CEO
Endpoints News 7 abr 2026 Novo launches high-dose Wegovy in the US; Evotec pressured to list its US unit
Endpoints News 1 abr 2026 Novo cuts 400 jobs in Indiana as Scholar Rock refiles drug linked to the factory
FierceBiotech 1 abr 2026 KBP hopes to revive troubled heart drug at center of deal fraud dispute with Novo Nordisk
Endpoints News 25 mar 2026 Novo reports more triple-G data from China; Grifols plots IPO for biopharma unit
FierceBiotech 25 mar 2026 Novo Nordisk prepares to go global as triple-G prospect passes midphase diabetes test in China